118 related articles for article (PubMed ID: 29207935)
1. Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib.
Hermel DJ; Chiu V; Hermel MH; Tulpule A; Akhtari M
J Oncol Pharm Pract; 2019 Apr; 25(3):699-702. PubMed ID: 29207935
[TBL] [Abstract][Full Text] [Related]
2. Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester.
Bayraktar S; Morency B; Escalón MP
BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22791487
[TBL] [Abstract][Full Text] [Related]
3. A dramatic fetal outcome following transplacental transfer of dasatinib.
Berveiller P; Andreoli A; Mir O; Anselem O; Delezoide AL; Sauvageon H; Chapuis N; Tsatsaris V
Anticancer Drugs; 2012 Aug; 23(7):754-7. PubMed ID: 22421368
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
5. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
[TBL] [Abstract][Full Text] [Related]
6. Experience with dasatinib and nilotinib use in pregnancy.
Barkoulas T; Hall PD
J Oncol Pharm Pract; 2018 Mar; 24(2):121-128. PubMed ID: 29284357
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Generic Dasatinib as a Second-line Treatment for Patients with Chronic Myeloid Leukemia: a Multicenter Retrospective Study in Hubei Province, China.
Chen LF; Yuan GL; Zhong ZD; Zou P; Li DJ; Bao Y; Ren HB; Meng L; Li WM
Curr Med Sci; 2018 Dec; 38(6):1005-1011. PubMed ID: 30536062
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
Ochiai S; Sato Y; Minakawa A; Fukuda A; Fujimoto S
BMC Nephrol; 2019 Mar; 20(1):87. PubMed ID: 30845905
[TBL] [Abstract][Full Text] [Related]
9. Chronic myelogenous leukemia presenting with osteonecrosis of the jaw as a rare but debilitating toxicity of dasatinib: a case report and literature review.
Won AM; Boddu P; Otun AO; Aponte-Wesson R; Chambers M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Oct; 126(4):e208-e211. PubMed ID: 29941400
[TBL] [Abstract][Full Text] [Related]
10. The impact of dasatinib on pregnancy outcomes.
Cortes JE; Abruzzese E; Chelysheva E; Guha M; Wallis N; Apperley JF
Am J Hematol; 2015 Dec; 90(12):1111-5. PubMed ID: 26348106
[TBL] [Abstract][Full Text] [Related]
11. [Successful child delivery in treatment-free remission of chronic myeloid leukemia after discontinuation of dasatinib].
Hirose N; Fujisawa S; Sakuma T; Matsumura A; Miyashita K; Nakajima Y; Nakajima H
Rinsho Ketsueki; 2022; 63(2):114-116. PubMed ID: 35264501
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].
Makeeva LM; Emelina EI; Gendlin GE; Nikitin IG; Vasyuk YA; Nesvetov VV
Kardiologiia; 2017 Apr; 57(S4):53-60. PubMed ID: 29466183
[TBL] [Abstract][Full Text] [Related]
13. [Pregnancy outcome among patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].
Jiang Q; Jiang B; Chen SS; Jiang H; Qin YZ; Lai YY; Shi HX; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):6-9. PubMed ID: 22575184
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.
Keskin D; Sadri S; Eskazan AE
Drug Des Devel Ther; 2016; 10():3355-3361. PubMed ID: 27784993
[TBL] [Abstract][Full Text] [Related]
15. The role of dasatinib in the management of chronic myeloid leukemia.
Chen R; Chen B
Drug Des Devel Ther; 2015; 9():773-9. PubMed ID: 25709401
[TBL] [Abstract][Full Text] [Related]
16. A case of long-term dasatinib-induced proteinuria and glomerular injury.
Koinuma K; Sakairi T; Watanabe Y; IIzuka A; Watanabe M; Hamatani H; Nakasatomi M; Ishizaki T; Ikeuchi H; Kaneko Y; Hiromura K
CEN Case Rep; 2020 Nov; 9(4):359-364. PubMed ID: 32388829
[TBL] [Abstract][Full Text] [Related]
17. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.
Bergeron A; Réa D; Levy V; Picard C; Meignin V; Tamburini J; Bruzzoni-Giovanelli H; Calvo F; Tazi A; Rousselot P
Am J Respir Crit Care Med; 2007 Oct; 176(8):814-8. PubMed ID: 17600277
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.
Kostos L; Burbury K; Srivastava G; Prince HM
Platelets; 2015; 26(8):809-11. PubMed ID: 26029798
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy in Patients With Chronic Myeloid Leukemia.
Berman E
J Natl Compr Canc Netw; 2018 May; 16(5S):660-662. PubMed ID: 29784750
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.
Schiffer CA; Cortes JE; Hochhaus A; Saglio G; le Coutre P; Porkka K; Mustjoki S; Mohamed H; Shah NP
Cancer; 2016 May; 122(9):1398-407. PubMed ID: 26998677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
